Proto Labs (PRLB) as of March 31, 2026 presents a balance sheet where liquidation recovery to equity is substantially positive on a gross basis but significantly constrained once intangibles and goodwill are zeroed out. Total assets of $778.6M carry approximately $274.0M in goodwill and $17.5M in finite-lived intangibles — combined $291.5M that receives a zero recovery haircut under the liquidation lens. Applying standard haircuts: cash and equivalents $124.0M at 100% = $124.0M; marketable securities $34.0M at ~100% (investment-grade short-duration instruments, Level 1/2) = $34.0M; net AR $85.6M at 90-95% = ~$77-81M; inventory net $14.9M at 60% = ~$8.9M; PP&E net $209.5M at 50-70% = ~$105-147M; intangibles/goodwill $291.5M at 0% = $0; other assets (prepaid, deferred tax, other noncurrent) ~$25M at modest recovery = ~$5-10M. Gross liquidation asset pool approximates $354-404M. Against total liabilities at face value of $95.4M (current $70.7M, noncurrent $24.7M including deferred tax liability $18.9M, operating lease noncurrent $1.4M, other long-term $4.4M), estimated net liquidation recovery to equity is approximately $260-310M. MFFAIS reports an operating liquidation value of $152.3M and liquid liquidation value of $137.4M — these are substantially lower, likely reflecting deeper PP&E haircuts and different treatment of the deferred tax liability and lease obligations. The primary driver of liquidation value impairment versus book equity ($683.1M) is the $291.5M intangibles/goodwill stack that recovers nothing. PP&E at $209.5M net book value (predominantly CNC, injection molding, and 3D printing equipment plus facility assets) is the largest single tangible recovery lever and carries significant uncertainty — specialized manufacturing equipment typically clears at 40-60% of book in forced liquidation, and cross-border assets (Europe segment carries $43.1M) add FX and jurisdiction risk. No new debt was incurred this quarter; the company carries no drawn credit facility. Restructuring charges of $1.4M in Q1 2026 (vs. zero in Q1 2025) signal ongoing organizational changes, but no material fixed-asset write-downs or PP&E impairments were recorded. AOCI stands at -$23.5M (vs. -$21.0M at December 31, 2025), driven by $2.4M of additional FTX translation loss in Q1 2026 as certain foreign currencies weakened versus USD. The $63.3M remaining under the February 2025 share repurchase authorization represents a contingent cash deployment that, in liquidation, would not be exercised.
▼ Community Notes